According to our latest market study, Cerebrospinal Fluid Management Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)," the market is expected to grow from US$ 1.82 billion in 2021 to US$ 2.61 billion by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.
Cerebrospinal fluid management companies worldwide are scaling up production. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in both domestic and international markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions.
The cerebrospinal fluid management market majorly consists of players such as Medtronic plc; Integra LifeSciences Corporation; B. Braun Melsungen AG; Depuy Synthes; Sophysa SA; BeckerSmith Medical; Biometri, Spiegelberg GmbH & Co; Moller Medical GmbH, and Dispomedica GmbH. These companies have been implementing various strategies that have helped the growth of the individual companies and in turn, have brought about various favorable changes in the market. The companies have utilized organic strategies such as launches and product approvals. Moreover, inorganic strategies such as mergers & acquisitions and collaborations were widely seen in the cerebrospinal fluid management market.
Several inorganic approaches such as product launches and expansion in the cerebrospinal fluid management market have resulted in the positive growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the companies to strengthen their revenue, which allows them to hold a strong position in the market.
The impact of COVID-19 has been far-reaching. The effects on neurological patients make them one of the worst affected groups. COVID-19 has greatly impacted the number of patients undergoing tumor diagnosis and treatment. The increased pressure due to the growing rate of hospitalization of COVID-19 patients led to the re-profiling of many hospitals and departments, including neurology clinics for treating patients with the COVID-19. The cerebrospinal fluid management market in Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. China and India are major contributors to the market growth, owing to the increasing incidences of CSF leaks and growing developments for CSF management products.
Read More @ https://www.theinsightpartners.com/reports/cerebrospinal-fluid-management-market
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1–646–491–9876